Asthma drug for kids under the microscope in new safety study
NCT ID NCT06427876
Summary
This study aims to monitor the safety and effectiveness of the asthma medication FASENRA in children aged 6 to 15 years. It will observe about 40 children with severe asthma who are starting FASENRA for the first time in real-world, everyday use. The main goal is to check for any unexpected side effects and see how well the drug helps control asthma and improve lung function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAichi, Japan
-
Research Site
RECRUITINGChiba, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGHiroshima, Japan
-
Research Site
RECRUITINGHokkaido, Japan
-
Research Site
RECRUITINGHyōgo, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGIbaraki, Japan
-
Research Site
RECRUITINGMie, Japan
-
Research Site
RECRUITINGOkayama, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGOsaka, Japan
-
Research Site
RECRUITINGOsaka, Japan
-
Research Site
RECRUITINGSaitama, Japan
Conditions
Explore the condition pages connected to this study.